Dupilumab in inflammatory skin diseases: a systematic review

H Olbrich, CD Sadik, RJ Ludwig, D Thaci, K Boch - Biomolecules, 2023 - mdpi.com
Dupilumab was first approved for the treatment of atopic dermatitis (AD) and blocks the
signaling of interleukin (IL)-4 and-13. Several other chronic skin conditions share …

Biological treatments for pediatric Netherton syndrome

M Pontone, M Giovannini, C Filippeschi… - Frontiers in …, 2022 - frontiersin.org
Netherton syndrome (NS) is a rare and potentially life-threatening genetic skin disease
responsible for skin inflammation and scaling, hair abnormalities and severe allergic …

Tailored treatments in inborn errors of immunity associated with atopy (IEIs-A) with skin involvement

C Giancotta, N Colantoni, L Pacillo, V Santilli… - Frontiers in …, 2023 - frontiersin.org
Inborn errors of immunity associated with atopy (IEIs-A) are a group of inherited monogenic
disorders that occur with immune dysregulation and frequent skin involvement. Several …

Biologics for inherited disorders of keratinisation: A systematic review

MKY Chen, AL Flanagan… - Australasian Journal of …, 2024 - Wiley Online Library
Abstract Background/Objectives Recent literature highlights the potential of biologics in the
management of inherited disorders of keratinisation. In this study, we conducted a …

Report of two sisters with Netherton syndrome successfully treated with dupilumab and review of the literature

C Martin-García, E Godoy, A Cabrera… - International …, 2023 - journals.sagepub.com
Different monoclonal antibodies have been used for the treatment of Netherton's syndrome
(NS); secukinumab (anti-IL17A), infliximab (anti-TNF-α), ustekinumab (anti p40 subunit of IL …

Treatment of Netherton syndrome with upadacitinib

X Li, B Han, S Li - Clinical and Experimental Dermatology, 2023 - academic.oup.com
We reported the case of a patient with Netherton syndrome (NS) who showed remarkable
cutaneous improvement using upadacitinib in the short term, but the efficacy decreased long …

Severe congenital ichthyosiform dermatosis in CHIME syndrome successfully treated with ixekizumab

LE Flowers, JA Dyer, KA Eisenstein - Pediatric Dermatology, 2024 - Wiley Online Library
Coloboma, congenital heart disease, ichthyosiform dermatosis, intellectual disability,
conductive hearing loss, and epilepsy (CHIME) syndrome is a rare autosomal recessive …

度普利尤单抗在罕见单基因遗传性皮肤病中的应用进展

张钰乔, 曾跃平 - 罕见病研究, 2023 - jrd.chard.org.cn
单基因遗传性皮肤病是一组临床罕见的疾病, 包括近1000 种表型不同的疾病.
通过全球皮肤学科及相关学科研究者的共同努力, 这些疾病的病因及发病机制研究在近30 …

Intravenous immunoglobulin for the management of Netherton syndrome

S Neema, B Vasudevan, A Rathod… - Indian Journal of …, 2023 - ijdvl.com
Erythroderma indicates generalized erythema and scaling involving more than 80–90%
body surface area. There is a long list of differentials for neonatal and infantile erythroderma …

[引用][C] Quoi de neuf en thérapeutique dermatologique?: What's new in dermatological treatment?

M Samimi - Annales de Dermatologie et de Vénéréologie-FMC, 2023 - Elsevier